🇺🇸 FDA
Patent

US 9044419

Vaccine compositions compromising βs-crystallin for inducing immune responses against components of drusen

granted A61KA61K39/0008A61P

Quick answer

US patent 9044419 (Vaccine compositions compromising βs-crystallin for inducing immune responses against components of drusen) held by Northwestern University expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K39/0008, A61P, A61P27/02, A61P37/00